≥98%HPLC Purity
COAIncluded
USAShipped
Pentapeptide-18 (Leuphasyl) Peptide
Enkephalin-like pentapeptide researched for reducing catecholamine release at the neuromuscular junction. Mimics the activity of enkephalins in modulating pain signaling.
Coming Soon
This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.
Quick Facts
| SKU | PEP18-001 |
|---|---|
| Purity | ≥98% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C |
What is Pentapeptide-18 (Leuphasyl)?
Pentapeptide-18 mimics enkephalins, binding to opioid receptors on presynaptic neurons. This reduces calcium channel opening and catecholamine (acetylcholine, norepinephrine) vesicle release. The effect is similar to Argireline but through an opioid receptor-mediated pathway rather than SNARE interference.
Frequently Asked Questions
How does Leuphasyl work vs Argireline?
Leuphasyl activates enkephalin/opioid receptors to reduce neurotransmitter release. Argireline interferes with the SNARE complex directly. Both reduce muscle contraction but through independent mechanisms, making them synergistic.
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.